# Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus

> **NCT03540212** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 50 (estimated)

## Conditions studied

- Chronic HCV Infection

## Interventions

- **DRUG:** Daclatasvir and sofosbuvir

## Key facts

- **NCT ID:** NCT03540212
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-10
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03540212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03540212, "Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03540212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*